Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
50 Cards in this Set
- Front
- Back
Site of action of loop diuretics
|
Thick ascending limb
|
|
SE of loop (furosemide) diuretics (3)
|
Hyperuricemia, hypokalemia and ototoxicity
|
|
Aminoglycosides used with loop diuretics potentiate adverse effect
|
Ototoxicity
|
|
Loops lose and thiazide diuretics retain
|
Calcium
|
|
MOA of thiazide diuretics
|
Inhibit Na+/Cl- cotransport
|
|
Site of action of thiazide diuretics
|
Work at early distal convoluted tubule
|
|
Class of drugs that may cause cross-sensitivity with thiazide diuretics
|
Sulfonamides
|
|
SE of thiazide (HCTZ) diuretics (3)
|
Hyperuricemia, hypokalemia and hyperglycemia
|
|
Potassium sparing diuretics inhibit
|
Na+/K+ exchange
|
|
Diuretic used to treat primary aldosteronism
|
Spironolactone
|
|
SE of spironolactone (3)
|
Gynecomastia, hyperkalemia, and impotence
|
|
Osmotic diuretic used to treat increased intracranial pressure
|
Mannitol
|
|
Section: Antidiuretic hormone (ADH) agonist and antagonist
|
|
|
ADH agonist used for pituitary diabetes insipidus
|
Desmopressin (DDAVP)
|
|
Used for SIADH
|
Demeclocycline
|
|
SE of demeclocycline
|
Bone marrow and teeth discoloration for children under 8 years of age
|
|
Antiarrhythmic agents
|
|
|
MOA of class I A (eg. Procainamide), class IB (eg. Lidocaine), and class IC (eg. Flecainide) antiarrhythmics
|
Sodium channel blockers
|
|
SE of procainamide
|
Lupus-like syndrome
|
|
Limiting side effect of Quinidine
|
Prolongs QT interval
|
|
Other side effects of Quinidine (2)
|
Thrombocytopenic purpura, and CINCHONISM
|
|
Major drug interaction with Quinidine
|
Increases concentration of Digoxin
|
|
DOC for management of acute ventricular arrhythmias
|
Amiodarone
|
|
DOC for digoxin induced arrhythmias
|
Phenytoin
|
|
SE of phenytoin
|
Gingival hyperplasia
|
|
Class of anti-arrhythmics that has a pro-arrhythmic effect (CAST trial), therefore are used as last line agents
|
Class IC (flecainide, propafenone, moricizine)
|
|
Class II antiarrhythmics are
|
B-blockers
|
|
Antiarrhythmic that exhibits Class II and III properties
|
Sotalol
|
|
Side effect of sotalol
|
prolongs QT and PR interval
|
|
Used intravenously for acute arrhythmias during surgery
|
Esmolol
|
|
Anti-arrhythmics that decrease mortality
|
B-blockers
B savin your life |
|
MOA of class III antiarrhythmics
|
Potassium channel blockers
|
|
Class III antiarrhythmic that exhibits properties of all 4 classes
|
Amiodarone
|
|
Specific pharmacokinetic characteristic of amiodarone
|
Prolonged half-life, up to six weeks
|
|
Antiarrhythmic effective in most types of arrhythmia
|
Amiodarone
|
|
SE of Amiodarone (6)
|
Cardiac dysfunction,
photosensitivity, skin (blue smurf syndrome), Pulmonary fibrosis, thyroid and corneal deposits |
|
MOA of class IV antiarrhythmics
|
Calcium channel blockers
|
|
Life threatening cardiac event that prolong QT leads to
|
Torsades de pointes
|
|
Agent to treat torsades de pointes
|
Magnesium sulfate
|
|
Drug used supraventricular arrhythmias
|
Digoxin
|
|
DOC for paroxysmal supraventricular tachycardia (PSVT)
|
Adenosine
|
|
Adenosine's MOA
|
Activation on an inward K+ current and inhibition of Ca++ current resulting in marked HYPERPOLARIZATION
|
|
Anti-arrhythmic with 15 second duration of action
|
Adenosine
|
|
Vasodilators and treatment of angina
|
|
|
MOA of sildenafil (Viagra)
|
Inhibits phosphodiesterase-5, enhancing effects of nitric oxide-activated increases in cGMP
|
|
Drugs used in the management of angina (4)
|
Aspirin, Nitrates, CCB, and Beta blockers
|
|
Aspirin reduces mortality in unstable angina by
|
Platelet aggregation inhibition
|
|
MOA of nitrates (3 parts)
|
Relax vascular smooth muscle,
at low doses dilate veins and at high doses dilate arterioles |
|
Nitrate used for acute anginal attacks
|
Nitroglycerin sublingual tablets
|
|
Nitrate used to prevent further attacks
|
Oral and transdermal forms of nitroglycerin
|